Skip to content

THE EFFECT OF ONLINE TRAINING ON FOOT CARE

THE EFFECT OF ONLINE TRAININGS ON DIABETIC FOOT CARE ON FOOT CARE BEHAVIOR AND SELF-EFFECTIVENESS ATTITUDES OF INDIVIDUALS WITH TYPE II DIABETES

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05473494
Enrollment
90
Registered
2022-07-26
Start date
2022-01-01
Completion date
2022-09-01
Last updated
2022-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot, Type2diabetes

Keywords

Type2diabetes, DiabeticFootCare, OnlineEducational, DistanceEducation, Self-Effectıveness

Brief summary

The aim of this study is to determine the effect of online trainings on diabetic foot care on foot care behavior and self-efficacy attitudes of individuals with type II diabetes. Purpose in accordance with the patient's Diagnostic Information Form, diabetic foot care self-efficacy Scale(DABOO), foot care Behavior Scale(ABDO) and diabetic foot risk screening forms are available in the data collection tools; education and Research Hospital Internal Medicine outpatient clinic with Deeply Izmit Seka state hospital, inpatient or outpatient treatment for persons with Type II diabetes who agree to volunteer to participate in research 90 shall apply. After that, the groups will be divided into two groups by randomization, and one of the groups will be given training sessions consisting of min 20 max 40 minutes for diabetic foot care in 5 sessions for nine weeks. After the training, the scales will be applied to the groups again. The data obtained before and after the training will be compared statistically in a computer environment

Interventions

OTHERtraining group

Trainings on diabetic foot care consisting of min 20 max 40 minutes will be given in 5 sessions for nine weeks. Training will be given face to face online.

OTHERcontrol group

Group not to be trained.

Sponsors

Maltepe University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients who were applied the Dietetic Foot Risk Screening form during the physician's examination and who were in the low and medium risk groups after the physician's examination. * To be able to read and write. * Being between the ages of 18-65. * Being on oral antidiabetic (OAD) and/or insulin therapy. * No restriction of access to the Internet. * To be able to use the Zoom program or WhatsApp video conversation with or without support. * Having computer and/or telephone skills. * Volunteering to participate in the study (Informed consent form will be signed by the participants during the application) * Not having sensory loss such as speech and hearing that prevents communication and no psychiatric problems.

Exclusion criteria

outside the inclusion criteria.

Design outcomes

Primary

MeasureTime frameDescription
Diabetic Foot Care Self-Efficacy Scalenine weeksSelf-efficacy is measured by scoring between 0 and 10. The 9 expressions that make up the scale are evaluated on the 11-digit visual scale, which is specified as -Not sure=0 and very sure=10. The lowest score of the scale is 0 and the highest score is 100. As the score obtained from the scale increases, the diabetic foot self-efficacy level increases in parallel.

Secondary

MeasureTime frameDescription
Foot Care Behavıor Scalenine weeksConsisting of 15 items in a 5-point Likert type, the scale is scored according to agree-disagree (1= Never, 2= Occasionally, 3= Sometimes, 4= Often, and 5= Always) and consists of 15 items. The lowest score that can be obtained from the scale, which evaluates foot care behavior as a single dimension, is 15 and the highest score is 75. An increase in the scale score indicates that the individual's foot self-care behaviors become positive.

Countries

Turkey (Türkiye)

Contacts

Primary ContactAyşegül Kandemir
aysegul.kanfe@hotmail.com5433837160

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026